MUMBAI, 21 September 2026 — Shukra Pharmaceuticals records same-day ex-date and record date for ₹0.01. The controlled description is Final Dividend — ₹0.0100, attached to NSE SHUKRAPHAR and BSE 524632.
Open the complete 57-issuer NSE-BSE corporate-action index to compare this company with every other September 21 entry.
Shukra Pharmaceuticals verified exchange fields
| Issuer | Shukra Pharmaceuticals Ltd |
|---|---|
| Exchange key | NSE SHUKRAPHAR and BSE 524632 |
| Cash action | Final Dividend — ₹0.0100 |
| Ex-date | 21 September 2026 |
| Record date | 21 September 2026 |
| Calendar position | 56 of 57 by nominal cash per share |
Shukra Pharmaceuticals small-value action
Shukra Pharmaceuticals is cross-listed in the source data as SHUKRAPHAR on NSE and 524632 on BSE. The final dividend is ₹0.01 per share and NSE reports face value of ₹1, so the declaration equals 1% of face value. A small cash figure still requires correct settlement and identification, and it remains a valid corporate action even though it sits near the bottom of the nominal-amount table. CapKet does not pad the story with a price forecast or imply that nominal size determines materiality for every holder. Both exchange references are retained, while the issuer is counted once and linked to the complete calendar.
SHUKRAPHAR keeps one-paise precision
A ₹0.01 dividend is one paisa per eligible share, so displaying extra zeros or rounding it away would reduce clarity. The source value is carried unchanged through the headline facts, table and metadata. SHUKRAPHAR and 524632 also prevent confusion with other pharmaceutical names. Holders should multiply the exact cash amount by eligible quantity before withholding to understand gross scale. The small nominal payment does not remove normal settlement, tax or market risk.
Investment disclaimer: This Shukra Pharmaceuticals report is exchange-sourced general information, not investment, tax or legal advice. It is not a recommendation, solicitation, price forecast or guarantee of payment.